ÉϺ£ÑÐÆôÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾
²úÆ·ÖÐÐÄ
΢ÉúÎïÁ×֬øD(PL-D£©ELISAÊÔ¼ÁºÐ
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
¶ÔϺ¶à°ÍÍÑôÈø(DOPA£©ELISAÊÔ¼ÁºÐ
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
蹻׳没IgM¿¹Ìå(toxocariasisIgMAb£©ELISAÊÔ¼ÁºÐ
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
蹻׳没IgG¿¹Ìå(toxocariasisIgGAb£©ELISAÊÔ¼ÁºÐ
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
¶ÔϺ΢ÄÒÔå¶¾ËØ-LR(MC-LR£©ELISAÊÔ¼ÁºÐ
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
õõϸС²¡¶¾¿¹Ìå(PV-Ab£©ELISAÊÔ¼ÁºÐ
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
΢ÉúÎïÖ¬·¾Ã¸(Lipase£©ELISAÊÔ¼ÁºÐ
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
ϸ¾úÏõËỹÔø(NR£©ELISAÊÔ¼ÁºÐ
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
ϸ¾úÑÇÏõËỹÔø(NiR£©ELISAÊÔ¼ÁºÐ
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
È®µ¥ºËϸ°ûÇ÷»¯µ°°×1(MCP-1£©ELISAÊÔ¼ÁºÐ
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
È®°ëÈéÌÇÄý¼¯ËØ3(Galectin-3£©ELISAÊÔ¼ÁºÐ
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
È®´«È¾ÐÔ¸ÎÑ׿¹Ìå(ICHVAb£©ELISAÊÔ¼ÁºÐ
¼Û¸ñ£º £¤1280.0
Ðͺţº48T
È®²¼Â³ÊϾú¿¹Ìå(BrucellaAb£©ELISAÊÔ¼ÁºÐ
¼Û¸ñ£º £¤1280.0
Ðͺţº48T